Search research articles
Contact Us
Filters
Showing results (111-120 of 146) with videos related to
Page
of 15
Sort By:
Trials
|
June 27, 2022
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial
Pablo Rojo, Cinta Moraleda, Alfredo Tagarro, et al.
Medicine
|
April 13, 2021
Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood
Beatriz Ruiz-Saez, Manuela Martín-Bejarano García, Ana Martinez de Aragon, et al.
The Pediatric Infectious Disease Journal
|
October 19, 2019
Role of Magnetic Resonance Imaging and Cranial Ultrasonography in Congenital Cytomegalovirus Infection
Daniel Blázquez-Gamero, María Soriano-Ramos, Ana Martínez de Aragón, et al.
Frontiers in Immunology
|
April 18, 2022
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy
Alessandra Ruggiero, Giuseppe Rubens Pascucci, Nicola Cotugno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2026
Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial
James Wyncoll, Rujirek Kamolrattana, Moherndran Archary, et al.
The Lancet. HIV
|
February 20, 2025
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
Ellen White, Cissy Kityo, Moira J Spyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 1, 2016
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia
, Eliane Rohner, Kurt Schmidlin, et al.
The Lancet. HIV
|
August 19, 2024
The long wait for long-acting HIV prevention and treatment formulations
Willem Daniel Francois Venter, Monica Gandhi, Simiso Sokhela, et al.
BMC Infectious Diseases
|
January 15, 2021
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
Cecilia L Moore, Anna Turkova, Hilda Mujuru, et al.
Frontiers in Immunology
|
March 6, 2024
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART
Kathleen Gärtner, Sara Domínguez-Rodríguez, Judith Heaney, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 146) with videos related to
Sort By:
Page
of 15
Trials
|
June 27, 2022
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial
Pablo Rojo, Cinta Moraleda, Alfredo Tagarro, et al.
Medicine
|
April 13, 2021
Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood
Beatriz Ruiz-Saez, Manuela Martín-Bejarano García, Ana Martinez de Aragon, et al.
The Pediatric Infectious Disease Journal
|
October 19, 2019
Role of Magnetic Resonance Imaging and Cranial Ultrasonography in Congenital Cytomegalovirus Infection
Daniel Blázquez-Gamero, María Soriano-Ramos, Ana Martínez de Aragón, et al.
Frontiers in Immunology
|
April 18, 2022
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy
Alessandra Ruggiero, Giuseppe Rubens Pascucci, Nicola Cotugno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2026
Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial
James Wyncoll, Rujirek Kamolrattana, Moherndran Archary, et al.
The Lancet. HIV
|
February 20, 2025
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
Ellen White, Cissy Kityo, Moira J Spyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 1, 2016
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia
, Eliane Rohner, Kurt Schmidlin, et al.
The Lancet. HIV
|
August 19, 2024
The long wait for long-acting HIV prevention and treatment formulations
Willem Daniel Francois Venter, Monica Gandhi, Simiso Sokhela, et al.
BMC Infectious Diseases
|
January 15, 2021
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
Cecilia L Moore, Anna Turkova, Hilda Mujuru, et al.
Frontiers in Immunology
|
March 6, 2024
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART
Kathleen Gärtner, Sara Domínguez-Rodríguez, Judith Heaney, et al.
Page
of 15